California Immunology Research and Cures Initiative
Plain-English Summary
Proposition 38 would authorize $8.4 billion in state general obligation bonds to fund immunology and immunotherapy research. The funding would be split between a UC-affiliated nonprofit medical research institute and a grant program for public or nonprofit universities and institutions. Half of the research must focus on cancer, heart disease, and Alzheimer’s, with the other half for discretionary use.
What each outcome does
If Proposition 38 passes, California will issue $8.4 billion in bonds to fund immunology and immunotherapy research, with specific allocations for certain diseases and institutions. Any resulting technology or drugs must be sold in California at 20% below the national average price.
If Proposition 38 fails, California will not authorize the $8.4 billion in bonds for immunology and immunotherapy research. The state will not establish the specified funding allocations or pricing requirements for derived technologies and drugs.
Who is funding each side
BallotPulse is non-partisan. We summarize each outcome in plain English and disclose the money on both sides. We do not tell you how to vote. Always read the official ballot text and decide for yourself.